|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/343 | |
| A61K 31/443 | |||
| C07D 307/80 | |||
| C07D 405/04 | |||
| C07D 405/10 |
| (11) | Number of the document | 3177285 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15829495.9 |
| Date of filing the European patent application | 2015-08-03 | |
| (97) | Date of publication of the European application | 2017-06-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/043352 |
| Date | 2015-08-03 |
| (87) | Number | WO 2016/022446 |
| Date | 2016-02-11 |
| (30) | Number | Date | Country code |
| 201462034809 P | 2014-08-08 | US |
| (72) |
CHEN, Helen, Y., US
DEMONG, Duane, US
FINKE, Paul, E., US
PLUMMER, Christopher, W., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | [5,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS |
| [5,6]-FUSED BICYCLIC ANTIDIABETIC COMPOUNDS |